Compounds > 3,4-methylenedioxyamphetamine

3,4-methylenedioxyamphetamine and mdl 28133a

3,4-methylenedioxyamphetamine has been researched along with mdl 28133a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Black, CK; Fadayel, GM; Humphreys, TM; Nieduzak, TR; Schmidt, CJ; Sorensen, SM; Taylor, VL	1

Other Studies

1 other study(ies) available for 3,4-methylenedioxyamphetamine and mdl 28133a

Article	Year
The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine. European journal of pharmacology, 1992, Sep-22, Volume: 220, Issue:2-3 Topics: 3,4-Methylenedioxyamphetamine; alpha-Methyltyrosine; Animals; Brain; Corpus Striatum; Dopamine; Electrophysiology; Levodopa; Male; Methyltyrosines; Neurons; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists	1992

Article

Year

The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.

European journal of pharmacology, 1992, Sep-22, Volume: 220, Issue:2-3

Topics: 3,4-Methylenedioxyamphetamine; alpha-Methyltyrosine; Animals; Brain; Corpus Striatum; Dopamine; Electrophysiology; Levodopa; Male; Methyltyrosines; Neurons; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists

1992